CLINICAL_TRIALS
trial_result
· 2013-02-26
Clinical Trial Update: Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Summary
Phase 2 trial results for gefitinib retreatment in non-small cell lung cancer have been posted following completion of the study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chonnam National University Hospital | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2013-02-26